0000950142-14-000940.txt : 20140423 0000950142-14-000940.hdr.sgml : 20140423 20140423164723 ACCESSION NUMBER: 0000950142-14-000940 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140423 DATE AS OF CHANGE: 20140423 GROUP MEMBERS: AISLING CAPITAL III LP GROUP MEMBERS: AISLING CAPITAL PARTNERS III LLC GROUP MEMBERS: AISLING CAPITAL PARTNERS III LP GROUP MEMBERS: ANDREW SCHIFF GROUP MEMBERS: DENNIS PURCELL GROUP MEMBERS: STEVE ELMS SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-42262 FILM NUMBER: 14779216 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AISLING CAPITAL III LP CENTRAL INDEX KEY: 0001444717 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 888 Seventh Avenue, 30th Fl CITY: New York STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6380 MAIL ADDRESS: STREET 1: 888 Seventh Avenue, 30th Fl CITY: New York STATE: NY ZIP: 10106 SC 13D/A 1 eh1400590_13da2-transenterix.htm AMENDMENT NO. 2 eh1400590_13da2-transenterix.htm
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
SCHEDULE 13D/A
 
Under the Securities Exchange Act of 1934
(Amendment No. 2)*


 
TransEnterix, Inc.
(Name of Issuer)
 
Common Stock, $0.001 par value per share
(Title of Class of Securities)
 
89366M102
(CUSIP Number)
 
Aisling Capital
888 Seventh Avenue, 30th Floor
New York, NY 10106
(212) 651-6380
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
April 21, 2014
(Date of Event Which Requires Filing of This Statement)
 

 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
 
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 


 
 
 

 

 
CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 2 of 11
 
 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Aisling Capital III, LP
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
8,335,819
8
SHARED VOTING POWER
 
-0-
9
SOLE DISPOSITIVE POWER
 
8,335,819
10
SHARED DISPOSITIVE POWER
 
-0-
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,335,819
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
13.6% (1)
 
14
TYPE OF REPORTING PERSON
 
PN
 
 

(1)
The calculation of the percentage is based on an aggregate of 61,341,547 shares of Common Stock deemed issued and outstanding as of April 21, 2014 (excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s prospectus supplement filed with the Securities Exchange Commission (the “SEC”) on April 15, 2014.
 
 
 
 

 
 
CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 3 of 11

 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Aisling Capital Partners III, LP
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
8,335,819
8
SHARED VOTING POWER
 
-0-
9
SOLE DISPOSITIVE POWER
 
8,335,819
10
SHARED DISPOSITIVE POWER
 
-0-
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,335,819
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
13.6% (1)
 
14
TYPE OF REPORTING PERSON
 
PN
 
 

(1)
The calculation of the percentage is based on an aggregate of 61,341,547 shares of Common Stock deemed issued and outstanding as of April 21, 2014 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s prospectus supplement filed with the SEC on April 15, 2014.
 
 
 
 
 
 

 
 
 
CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 4 of 11

 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Aisling Capital Partners III LLC
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
8,335,819
8
SHARED VOTING POWER
 
-0-
9
SOLE DISPOSITIVE POWER
 
8,335,819
10
SHARED DISPOSITIVE POWER
 
-0-
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,335,819
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
13.6% (1)
 
14
TYPE OF REPORTING PERSON
 
OO
 
 

(1)
The calculation of the percentage is based on an aggregate of 61,341,547 shares of Common Stock deemed issued and outstanding as of April 21, 2014 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s prospectus supplement filed with the SEC on April 15, 2014.
 
 
 
 
 

 
 
CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 5 of 11

  
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Steve Elms
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
8,335,819
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
8,335,819
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,335,819
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
13.6% (1)
 
14
TYPE OF REPORTING PERSON
 
IN
 
 

(1)
The calculation of the percentage is based on an aggregate of 61,341,547 shares of Common Stock deemed issued and outstanding as of April 21, 2014 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s prospectus supplement filed with the SEC on April 15, 2014.
 
 
 
 

 
 
 
CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 6 of 11

 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Dennis Purcell
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
8,335,819
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
8,335,819
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,335,819
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
13.6% (1)
 
14
TYPE OF REPORTING PERSON
 
IN
 
 

(1)
The calculation of the percentage is based on an aggregate of 61,341,547 shares of Common Stock deemed issued and outstanding as of April 21, 2014 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s prospectus supplement filed with the SEC on April 15, 2014.
 
 
 
 

 
 
 
CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 7 of 11

  
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Andrew Schiff
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
8,335,819
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
8,335,819
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,335,819
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
13.6% (1)
 
14
TYPE OF REPORTING PERSON
 
IN
 
 

(1)
The calculation of the percentage is based on an aggregate of 61,341,547 shares of Common Stock deemed issued and outstanding as of April 21, 2014 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s prospectus supplement filed with the SEC on April 15, 2014.
 
 
 
 

 
 
CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 8 of 11
 
 
Item 1.
Security and Issuer.
 
This Amendment No. 2 to Schedule 13D (this “Statement”) amends and supplements the Schedule 13D as previously filed by the undersigned Reporting Persons (as defined below) on September 13, 2013, and amended by Amendment No. 1 to the Schedule 13D, filed by the Reporting Persons on December 10, 2013, with respect to the Common Stock, $0.001 par value (the “Common Stock”), of TransEnterix, Inc. (f/k/a SafeStitch Medical, Inc. and Cellular Technical Services Company, Inc.), a Delaware corporation (the “Issuer”). The principal executive office of the Issuer is located at 635 Davis Drive, Suite 300, Durham, North Carolina 27713.
 
Item 2.
Identity and Background.

No material change.

Item 3.
Source and Amount of Funds or Other Consideration.
 
No material change.
 
Item 4.
Purpose of Transaction.

Item 4 of the Schedule 13D is hereby supplemented as follows:

“On March 31, 2014, the Issuer implemented a reverse stock split of the Common Stock at a ratio of 1−for−5. The reverse stock split applied to all of the Company’s issued and outstanding Common Stock and therefore did not affect any stockholder’s relative ownership percentage.”

Item 5.
Interest in Securities of the Issuer.
 
 
Items 5(a), (b) and (c) are amended and restated in their entirety as follows:
 
(a) The aggregate percentage of shares of Common Stock reported as owned by each Reporting Person is based on  61,341,547 shares of Common Stock issued and outstanding as reported in the Issuer’s prospectus supplement filed with the SEC on April 15, 2014 (excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock).  Based on calculations made in accordance with Rule 13d 3(d), the Reporting Persons beneficially own in the aggregate 8,335,819 shares of Common Stock, representing 13.6% of the total issued and outstanding shares of Common Stock.
 
       
Aisling Capital III, LP
Aisling Capital Partners III, LP
Aisling Capital Partners III LLC
 
Common
Stock
 
Amount beneficially owned:
    8,335,819  
Percent of class:
       
(i) Sole voting power
    13.6 %
(ii) Shared voting power
    0  
(iii) Sole dispositive power
    13.6 %
(iv) Shared dispositive power
    0  
 
 
 

 
 
 
CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 9 of 11

 
Steve Elms
Dennis Purcell
Andrew Schiff
  
Common
Stock
 
Amount beneficially owned:
  
 
8,335,819
  
Percent of class:
  
     
(i) Sole voting power
  
 
0
  
(ii) Shared voting power
  
 
13.6
(iii) Sole dispositive power
  
 
0
  
(iv) Shared dispositive power
  
 
13.6
 
(b)
 
(i) Each of Aisling, Aisling Partners and Aisling Partners GP may be deemed to have sole power to direct the voting and disposition of the 8,335,819 shares of Common Stock that may be deemed to be beneficially owned by the Reporting Persons.
 
Aisling Capital III, LP
Aisling Capital Partners III, LP
Aisling Capital Partners III LLC
  
Common
Stock
 
Amount beneficially owned:
  
 
8,335,819
  
Percent of class:
  
     
(i) Sole voting power
  
 
13.6
(ii) Shared voting power
  
 
0
  
(iii) Sole dispositive power
  
 
13.6
(iv) Shared dispositive power
  
 
0
  
 
(ii) By virtue of the relationships between and among the Reporting Persons described in Item 2 of this Schedule 13D, each of the Messrs. Elms, Purcell and Schiff may be deemed to share the power to direct the voting and disposition of the 8,335,819 shares of Common Stock beneficially owned by the Reporting Persons.
 
Steve Elms
Dennis Purcell
Andrew Schiff
  
Common
Stock
 
Amount beneficially owned:
  
 
8,335,819
  
Percent of class:
  
     
(i) Sole voting power
  
 
0
  
(ii) Shared voting power
  
 
13.6
(iii) Sole dispositive power
  
 
0
  
(iv) Shared dispositive power
  
 
13.6
 
(c) Recent Transactions. On April 21, 2014, the Issuer sold 12,500,000 shares of Common Stock in a public offering with an offering price of $4.00 per share. Aisling purchased 1,037,767 shares of Common Stock in the offering.”
 
Item 6.
Contract, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
 
No material change.
 
 
 
 

 
 
 
CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 10 of 11

 
 
Item 7.
Material to Be Filed as Exhibits.
 
The following documents are filed as exhibits hereto:
 
Exhibit 1:
  
Statement Appointing Designated Filer dated as of September 13, 2013, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (incorporated herein by reference to Exhibit 1 to Schedule 13D filed by the Reporting Persons on September 13, 2013).
 
 
 
 

 

 
CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 11 of 11

 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Date: April 23, 2014
AISLING CAPITAL III, LP
 
     
By:
Aisling Capital Partners III, LP
 
 
General Partner
 
     
By:
Aisling Capital Partners III LLC
 
 
General Partner
 
     
By:
/s/ Dennis Purcell
 
 
Name: Dennis Purcell
 
 
Title: Managing Member
 
     
     
AISLING CAPITAL PARTNERS III, LP
 
     
By:
Aisling Capital Partners III LLC
 
 
General Partner
 
     
     
By:
/s/ Dennis Purcell
 
 
Name: Dennis Purcell
 
 
Title: Managing Member
 
     
     
AISLING CAPITAL PARTNERS III LLC
 
     
     
By:
/s/ Dennis Purcell
 
 
Name: Dennis Purcell
 
 
Title: Managing Member
 
     
     
By:
/s/ Steve Elms
 
 
Steve Elms
 
     
     
By:
/s/ Dennis Purcell
 
 
Dennis Purcell
 
     
     
By:
/s/ Andrew Schiff
 
 
Andrew Schiff